Ranked #5 in the nation by U.S. News & World Report
Interstitial lung diseases (ILD) are a group of non-cancerous disorders characterized by widespread inflammation and scarring of the lung; they are commonly referred to as pulmonary fibrosis. Patients typically experience coughing and shortness of breath with ILD.
A recognized leader in the care of ILD patients, Duke’s Interstitial Lung Disease Program sees hundreds of newly referred patients every year.
We also serve patients with pulmonary conditions caused by rheumatic and autoimmune disorders such as lupus, rheumatoid arthritis, and scleroderma.
In addition, Duke has a world-famous lung transplantation program, and we routinely consider patients with progressive ILD for transplant if appropriate. Duke is well qualified to offer state-of-the-art, comprehensive care to patients with severe ILD.
In an effort to develop more effective ways of diagnosing and treating these conditions, Duke maintains an active research program that continues to make strides in understanding ILDs on a cellular level. Our ILD patients have the opportunity to participate in a number of clinical drug trials.
To learn more about the services Duke Medicine provides to patients with interstitial lung diseases, or to schedule an appointment or get a referral, call 919-668-7630 locally or 888-ASK-DUKE (888-275-3853) toll-free.
Physicians offering this service include:
This service is available at: